20/20 GENESYSTEMS, INC. SERIES C PREFERRED STOCK SUBSCRIPTION AGREEMENT NOTICE TO SUBSCRIBERSSeries C Preferred Stock Subscription Agreement • July 8th, 2020 • 20/20 GeneSystems, Inc. • Services-testing laboratories • Delaware
Contract Type FiledJuly 8th, 2020 Company Industry JurisdictionTHIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, SUBSCRIBERS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES.